Latest News

Check out what is happening at HCD Economics

February 2023

Informal Care

Informal care is generally thought to mean unpaid care, typically provided to elderly and dependent persons by those they have a social relationship with. Such as a spouse, parent, child or other relative. As well as maybe a neighbour or close friend.
Continue Reading
January 2023

Innovative evidence methods and their practical application in improving patient’s lives A review of 2022 news content published by the Prime Global evidence specialist - HCD Economics

Our news coverage in 2022, has focused on our commitment to generating evidence to inform decisions that deliver health equity. Our news reports share methodologies and results from our innovative research programme covering a wide range of disease areas and applied health economic analytical techniques.
Continue Reading
December 2022

Preference Research in Rare Disease

Approximately 6,000–7,000 of the 30,000 known diseases could be defined as rare or orphan diseases with a prevalence threshold of around 40-50 cases per 100,000 people. Meaning the total global prevalence of rare disease is around 5%, or 400 million people worldwide. With over 30 million rare disease sufferers living in the EU and 25 million from the US.
Continue Reading
Scroll for more

About us

HCD was created out of an alliance with University of Chester, charities and health service sectors in reponse to the ever-growing demand for economic analysis within healthcare and specifically the need for health economics and business intelligence within the public and third sectors.

Through these partnerships, HCD provides a unique insight and perspective, focusing our analyses on what matters to patients as well as decision-makers, all undertaken with academic rigour, independence and credibility.

Continue Reading
Scroll for more

Our Process

We have created core partnerships with University of Chester and leading patient charities that underpin our approach.

Higher education

Academia has a leading role to play in providing an independent, credible evidence-base as well as evaluating current and new ways of delivering healthcare.


Our partnerships with patient charities ensure that any analyses we undertake reflect the day-to-day realities of living with a particular condition.


We apply primary or secondary real world data sources depending on research needs and questions. From ethically reviewed burden of illness studies and bespoke service primary data, to secondary sourced disease registries and episode statistics.

Scroll for more

Get in touch

...and one of our experts will get back to you ASAP.

Please be advised that we will not use your details for marketing purposes
Scroll for more
Scroll for more